Pharmaceuticals, Biotechnology and Life Sciences
ZUG, Switzerland, July 24, 2025 (GLOBE NEWSWIRE) — Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral…
CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of…
Company to share primary endpoint results at 32-Weeks from Extension phase following late-breaking presentations at Alzheimer’s Association International Conference® (AAIC)…
BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing…
SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,…
LONDON, July 24, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a…
– Special Meeting of Stockholders to be Held Virtually on September 5, 2025 – – Live Stockholder Fireside Chat to…
REDWOOD CITY, Calif., July 24, 2025 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs)RESEARCH TRIANGLE PARK, N.C., July…
Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or…